Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.

Antimicrobial Agents and Chemotherapy
H AnwarJ W Costerton

Abstract

Pseudomonas aeruginosa was cultivated at low growth rates under iron-limiting conditions on acrylic tiles. Biofilm cells exhibited increased tobramycin resistance compared with that of planktonic cells, and in old biofilms were more resistant than were cells in young biofilms. However, on suspension of the biofilm bacteria, glycocalyx-mediated resistance was lost.

References

Mar 1, 1978·Microbiological Reviews·E D Weinberg
Jun 1, 1977·Bacteriological Reviews·H Smith
Apr 1, 1988·Canadian Journal of Microbiology·J W Costerton
May 1, 1987·Journal of Clinical Microbiology·J L KadurugamuwaK H Ward
Mar 1, 1988·Antimicrobial Agents and Chemotherapy·J L KadurugamuwaO Zak
Jan 1, 1987·Annual Review of Microbiology·J W CostertonT J Marrie
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·B L ProsserR Cleeland
Feb 1, 1987·The Journal of Applied Bacteriology·C W KeevilT W Feary
Jan 1, 1985·Annual Review of Microbiology·M R Brown, P Williams
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
Jan 1, 1984·Physiological Reviews·E D Weinberg

❮ Previous
Next ❯

Citations

May 29, 2000·Journal of Biomedical Materials Research·K A PoelstraH J Busscher
Dec 18, 2001·Journal of Biomedical Materials Research·G L Y WooJ P Santerre
Sep 1, 1995·Journal of Industrial Microbiology·N Khardori, M Yassien
Oct 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A PascualE J Perea
Oct 5, 2006·Analytical and Bioanalytical Chemistry·Thomas Bjarnsholt, Michael Givskov
Jul 2, 2005·Neurosurgical Review·Ernest E BraxtonJ Christopher Post
Feb 11, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·G Owusu-AbabioH Anwar
Jan 25, 2003·Diagnostic Microbiology and Infectious Disease·Marta MonzónBeatriz Amorena
Oct 1, 1996·International Journal of Antimicrobial Agents·C A PrestonJ W Costerton
Dec 1, 1993·The Journal of Applied Bacteriology·B Carpentier, O Cerf
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·H AnwarJ W Costerton
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·M R Millar, J Pike
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·H AnwarJ W Costerton
Jul 1, 1992·Antimicrobial Agents and Chemotherapy·H AnwarJ W Costerton
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·P A SuciG G Geesey
May 1, 1995·Antimicrobial Agents and Chemotherapy·H KumonJ C Nickel
May 6, 2006·American Journal of Respiratory and Critical Care Medicine·Timothy D StarnerPaul B McCray
May 30, 2002·American Journal of Respiratory Cell and Molecular Biology·Chieh-Liang WuJeffrey A Kazzaz
May 2, 2007·Journal of Periodontology·Kazuhiro GomiTakashi Arai
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Oct 16, 2004·Expert Review of Anti-infective Therapy·Christoph A FuxJ William Costerton
Feb 10, 2007·Expert Review of Proteomics·Ildikó KustosFerenc Kilár
Oct 31, 2012·International Journal of Food Microbiology·Olivier FirmesseBrigitte Carpentier
Mar 9, 2005·Oral Diseases·J GreenmanJ Duffield
May 7, 2009·Pediatric Pulmonology·Thomas BjarnsholtNiels Høiby
Aug 26, 2006·Periodontology 2000·Ricardo P TelesSigmund S Socransky
Jan 24, 2008·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Thomas BjarnsholtMichael Givskov
Aug 19, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Thomas BjarnsholtMichael Givskov
May 3, 2013·APMIS. Supplementum·Thomas Bjarnsholt
Sep 1, 1994·Medical Hypotheses·J W Warren
Oct 4, 2005·Colloids and Surfaces. B, Biointerfaces·Valéria GaálIldikó Kustos
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·P Vaudaux
Oct 10, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Koichi MondenHiromi Kumon
Oct 6, 2000·Annual Review of Microbiology·U SzewzykK H Schleifer
Dec 3, 2014·Journal of Microbiological Methods·Julie A K McDonaldEmma Allen-Vercoe
Apr 1, 1997·Advances in Dental Research·J W Wimpenny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.